BaconRNewmanSRankinLPitcairnGWhitingR. Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration. Int J Pharm. 2012;431(1-2):39-44.
2.
JalladNSGargDCMartinezJJMroszczakEJWeidlerDJ. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. J Clin Pharmacol. 1990;30(1):76-81.
3.
MatavaMBraterDCGritterN. Recommendations of the National Football League Physician Society Task Force on the use of Toradol® (ketorolac) in the National Football League. Sports Health. 2012;4(5): 377-383.
4.
MroszczakEJJungDYeeJBynumLSeveliusHMasseyI. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy. 1990;10(6):33S-39S.
